Homer Pearce

Homer L.
Pearce is currently a Director at BioNumerik Pharmaceuticals, Inc., a Director at Apexian Pharmaceuticals, Inc., a Member of the American Chemical Society, a Member of the American Association for Cancer Research, and an Advisory Board member at Accelerator Services Corp.
Previously, he was an Independent Director at Sunesis Pharmaceuticals, Inc. from 2006 to 2021, a Director & Scientific Advisor at Kylin Therapeutics, Inc. from 2009 to 2013, a Director at BlinkBio, Inc., a Director at Catena Pharmaceuticals, Inc., and the VP-Cancer Research & Clinical Investigation at Eli Lilly & Co. from 1994 to 2006.
He was also a Member of the American Association for the Advancement of Science.
Pearce received his doctorate from Harvard University in 1979 and his undergraduate degree from Texas A&M University in 1974.